These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 12973123)

  • 1. Cyclosporine A-induced achalasia-like esophageal motility disorder in a liver transplant recipient: successful conversion to tacrolimus.
    Koch R; Zoller H; Graziadei I; Propst A; Vogel W
    Transplantation; 2003 Aug; 76(4):744-5. PubMed ID: 12973123
    [No Abstract]   [Full Text] [Related]  

  • 2. Switch to tacrolimus for cyclosporine-induced gynecomastia in liver transplant recipients.
    Iaria G; Urbani L; Catalano G; De Simone P; Carrai P; Petruccelli S; Morelli L; Coletti L; Garcia C; Liermann R; Mosca F; Filipponi F
    Transplant Proc; 2005; 37(6):2632-3. PubMed ID: 16182769
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A retrospective study of conversion from tacrolimus-based to sirolimus-based immunosuppression in orthotopic liver transplant recipients.
    Yu S; He X; Yang L; Ma Y; Zhu X; Ju W; Huang J
    Exp Clin Transplant; 2008 Jun; 6(2):113-7. PubMed ID: 18816237
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Conversion to cyclosporine provides valuable rescue therapy for living donor adult liver transplant patients intolerant to tacrolimus: A single-center experience at the University of Tokyo.
    Tamura S; Sugawara Y; Kishi Y; Akamatsu N; Kaneko J; Murai N; Makuuchi M
    Transplant Proc; 2004 Dec; 36(10):3242-4. PubMed ID: 15686738
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of changing immunosuppressive monotherapy from Cyclosporin A to Tacrolimus in long-term, stable liver transplant recipients.
    Ott R; Bussenius-Kammerer M; Reck T; Koch CA; Kissler H; Hohenberger W; Müller V
    Transpl Int; 2004 Jan; 17(1):39-43. PubMed ID: 14504723
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Conversion from tacrolimus to cyclosporine--a based immunosuppression following liver transplantation.
    Doria C; Jain AK; Scott VL; Gruttadauria S; Marino IR; Doyle HR; Fung JJ
    Exp Clin Transplant; 2003 Jun; 1(1):48-55. PubMed ID: 15859907
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recurrence of migraine with aura due to tacrolimus therapy in a liver transplant recipient successfully treated with sirolimus substitution.
    Toth CC; Burak K; Becker W
    Headache; 2005 Mar; 45(3):245-6. PubMed ID: 15836601
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Conversion to tacrolimus and atorvastatin in cyclosporine-treated heart transplant recipients with dyslipidemia refractory to fluvastatin.
    Skalicka B; Kubanek M; Malek I; Vymetalova Y; Hoskova L; Podzimkova M; Kautzner J
    J Heart Lung Transplant; 2009 Jun; 28(6):598-604. PubMed ID: 19481021
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiac hypertrophy in liver transplant recipients: tacrolimus, cyclosporine or both?
    Therapondos G; Plevris JN; Dollinger MM; Hayes PC; Flapan AD
    Transplantation; 2003 Jul; 76(2):446-7; author reply 447-8. PubMed ID: 12883220
    [No Abstract]   [Full Text] [Related]  

  • 10. Gingival overgrowth in a renal transplant recipient using cyclosporine A.
    Gonçalves SC; Díaz-Serrano KV; de Queiroz AM; Palioto DB; Faria G
    J Dent Child (Chic); 2008; 75(3):313-7. PubMed ID: 19040821
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Do immunosuppressive agents really impair glucose tolerance in liver transplant patients?].
    Petrides AS
    Z Gastroenterol; 1995 Jul; 33(7):414-5. PubMed ID: 7571761
    [No Abstract]   [Full Text] [Related]  

  • 12. Long-term evaluation of cyclosporine and tacrolimus based immunosuppression in pediatric liver transplantation.
    Hasenbein W; Albani J; Englert C; Spehr A; Grabhorn E; Kemper MJ; Burdelski M; Ganschow R
    Pediatr Transplant; 2006 Dec; 10(8):938-42. PubMed ID: 17096762
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A numerical scale comparison of renal transplant recipient experience with and opinions about calcineurin inhibitors.
    Prasad GV; Nash MM; McFarlane PA; Zaltzman JS
    Nephron Clin Pract; 2004; 97(2):c35-40. PubMed ID: 15218328
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Conversion from tacrolimus to cyclosporine microemulsion therapy in liver transplant recipients.
    Ogino S; Hashikura Y; Katsuyama Y; Ikegami T; Nakazawa Y; Urata K; Terada M; Miyagawa S; Kawasaki S
    Transplant Proc; 2004 Mar; 36(2 Suppl):299S-301S. PubMed ID: 15041357
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microemulsion cyclosporine with C2 monitoring and tacrolimus in liver transplantation with or without hepatitis C virus infection.
    Jain A
    Liver Transpl; 2006 Oct; 12(10):1452-4. PubMed ID: 17004248
    [No Abstract]   [Full Text] [Related]  

  • 16. Liver transplantation for hepatocellular carcinoma under calcineurin inhibitors: reassessment of risk factors for tumor recurrence.
    Vivarelli M; Cucchetti A; La Barba G; Ravaioli M; Del Gaudio M; Lauro A; Grazi GL; Pinna AD
    Ann Surg; 2008 Nov; 248(5):857-62. PubMed ID: 18948815
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reversal of tacrolimus-related hypertrophic obstructive cardiomyopathy 5 years after kidney transplant in a 6-year-old recipient.
    Jarzembowski TM; John E; Panaro F; Manzelli A; Cabrera A; Greco A; Varga P; Sankary H; Testa G; Benedetti E
    Pediatr Transplant; 2005 Feb; 9(1):117-21. PubMed ID: 15667624
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improved liver function and decreased hepatitis C viral load after tacrolimus was replaced by cyclosporine.
    Lorho R; Turlin B; de Lajarte-Thirouard AS; Camus C; Lakehal M; Compagnon P; Meunier B; Boudjema K; Messner M
    Transplant Proc; 2005; 37(6):2871-2. PubMed ID: 16182838
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Conversion from cyclosporine to tacrolimus stabilizes the course of lung function in lung transplant recipients with bronchiolitis obliterans syndrome.
    Borro JM; Bravo C; Solé A; Usetti P; Zurbano F; Lama R; De la Torre M; Román A; Pastor A; Laporta R; Cifrián JM; Santos F
    Transplant Proc; 2007 Sep; 39(7):2416-9. PubMed ID: 17889206
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 12-month follow-up analysis of a multicenter, randomized, prospective trial in de novo liver transplant recipients (LIS2T) comparing cyclosporine microemulsion (C2 monitoring) and tacrolimus.
    Levy G; Grazi GL; Sanjuan F; Wu Y; Mühlbacher F; Samuel D; Friman S; Jones R; Cantisani G; Villamil F; Cillo U; Clavien PA; Klintmalm G; Otto G; Pollard S; McCormick PA
    Liver Transpl; 2006 Oct; 12(10):1464-72. PubMed ID: 17004259
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.